Christopher Paul Blackwell

Christopher Paul Blackwell

Direttore/Membro del Consiglio presso
AGI Therapeutics Plc
64 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Christopher Paul Blackwell is a former Chief Executive Officer of Vectura Group Ltd. He also served as an Executive Director at Scotia Pharmaceuticals Ltd. and as a Clinical Pharmacologist at GlaxoSmithKline Research & Development Ltd. Currently, he is a Non-Executive Director at AGI Therapeutics Plc.
He was also a Non-Executive Chairman at Nuformix Plc from 2018 to 2021.
He holds a doctorate degree from the University of Bath, which he received in 1988.

Posizioni attive di Christopher Paul Blackwell

SocietàPosizioneInizio
Direttore/Membro del Consiglio 11/04/2007

Precedenti posizioni note di Christopher Paul Blackwell

SocietàPosizioneFine
NUFORMIX PLC Presidente 10/02/2021
VECTURA GROUP Amministratore Delegato 01/07/2015
Direttore/Membro del Consiglio -
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Christopher Paul Blackwell

Formazione di Christopher Paul Blackwell

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

66

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Distribution Services

Health Technology

  1. Mercati
  2. Insiders
  3. Christopher Paul Blackwell